1 suspended. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Revlimid: new trials by email Literature Review of Revlimid trials Research Report on Revlimid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients Lenalidomide, Luspatercept - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Suspended | Mikkael Sekeres, MD | 50 | 2021-11-09 | 2026-07-17 |
United States (1)